We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 1,904 results
  1. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

    The MAPT gene, encoding the microtubule-associated protein tau on chromosome 17q21.31, is result of an inversion polymorphism, leading to two allelic...

    Christina V. Tauber, Sigrid C. Schwarz, ... Günter U. Höglinger in Acta Neuropathologica Communications
    Article Open access 11 March 2023
  2. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration

    Early pathological features of frontotemporal lobar degeneration (FTLD) due to MAPT pathogenic variants (FTLD-MAPT) are understudied, since...

    Lucia AA Giannini, Merel O Mol, ... Harro Seelaar in Acta Neuropathologica Communications
    Article Open access 02 August 2023
  3. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

    Tau plays a key role in Alzheimer’s disease (AD) pathophysiology, and accumulating evidence suggests that lowering tau may reduce this pathology. We...

    Catherine J. Mummery, Anne Börjesson-Hanson, ... Roger M. Lane in Nature Medicine
    Article Open access 24 April 2023
  4. Clinical features and biomarkers of semantic variant primary progressive aphasia with MAPT mutation

    Background

    Semantic variant primary progressive aphasia (svPPA) is generally sporadic, with very few reports of tau pathology caused by MAPT mutations.

    ...
    Jing Xu, Yanmin Xia, ... Nan Zhang in Alzheimer's Research & Therapy
    Article Open access 27 January 2023
  5. Methylation of MAPT Gene in Neurodegenerative Synucleinopathies

    Abstract

    Synucleinopathies are neurodegenerative disorders characterized by the accumulation of pathological aggregates of alpha-synuclein protein in...

    E. V. Iakovenko, N. Yu. Abramycheva, ... S. N. Illarioshkin in Russian Journal of Genetics
    Article 15 May 2022
  6. Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial

    Background

    In MAPT (Multidomain Alzheimer Preventive Trial), a cognitive effect of multidomain intervention (MI) was showed in non-demented subjects...

    Julien Delrieu, Bruno Vellas, ... Nicola Coley in Alzheimer's Research & Therapy
    Article Open access 23 October 2023
  7. Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer’s disease

    Alzheimer’s disease (AD) is the most common neurodegenerative disorder, and is caused by multiple pathological factors, such as the overproduction of...

    Qiyao Wang, Chenglong Xia, ... Wei Cui in Metabolic Brain Disease
    Article 09 May 2023
  8. A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy

    Right temporal variant frontotemporal dementia, also called right-predominant semantic dementia, often has an unclear position within the framework...

    Kohji Mori, Kazue Shigenobu, ... Manabu Ikeda in Acta Neuropathologica Communications
    Article Open access 10 August 2023
  9. Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia

    Frontotemporal dementia is characterized by progressive atrophy of frontal and/or temporal cortices at an early age of onset. The disorder shows...

    Suzanne S. M. Miedema, Merel O. Mol, ... August B. Smit in Acta Neuropathologica Communications
    Article Open access 07 July 2022
  10. Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases

    A ~ 1 Mb inversion polymorphism exists within the 17q21.31 locus of the human genome as direct (H1) and inverted (H2) haplotype clades. This...

    Chiara Pedicone, Sarah A. Weitzman, ... Alison M. Goate in Molecular Neurodegeneration
    Article Open access 29 May 2024
  11. Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations

    Numerous kindreds with familial frontotemporal lobar degeneration have been linked to mutations in microtubule-associated protein tau (MAPT) or...
    Bradley F. Boeve, Howard Rosen in Frontotemporal Dementias
    Chapter 2021
  12. Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers

    Background

    PET imaging of glucose metabolism has revealed presymptomatic abnormalities in genetic FTD but has not been explored in MAPT P301L...

    Mica T. M. Clarke, Frédéric St-Onge, ... Robert Laforce Jr in Alzheimer's Research & Therapy
    Article Open access 10 February 2021
  13. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features

    The microtubule-associated protein tau ( MAPT ) H1 haplotype is the strongest genetic risk factor for corticobasal degeneration (CBD). However, the...

    Rebecca R. Valentino, Shunsuke Koga, ... Michael G. Heckman in Acta Neuropathologica Communications
    Article Open access 07 December 2020
  14. Directly Reprogrammed Neurons Express MAPT and APP Splice Variants Pertinent to Ageing and Neurodegeneration

    Neurons produced by reprogramming of other cell types are used to study cellular mechanisms of age-related neurodegenerative diseases. To model...

    Mette Habekost, Per Qvist, ... Arne Lund Jørgensen in Molecular Neurobiology
    Article Open access 07 January 2021
  15. Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer’s disease

    Alzheimer's disease is associated with various brain dysfunctions, including memory impairment, neuronal loss, astrocyte activation, amyloid-β...

    Sung Hyun Tag, Baeksun Kim, ... Heh-In Im in Molecular Brain
    Article Open access 08 June 2022
  16. Phenotype Heterogeneity and Genotype Correlation of MAPT Mutations in a Chinese PUMCH Cohort

    Frontotemporal dementia (FTD) is a heterogeneous disease both clinically and pathologically. Genetic mutation in microtubule-associated protein tau ( MAPT...

    Chenhui Mao, Liling Dong, ... Jing Gao in Journal of Molecular Neuroscience
    Article 01 October 2020
  17. The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial

    Background

    The Multidomain Alzheimer Preventive Trial (MAPT) was designed to assess the efficacy of omega-3 fatty acid supplementation, multidomain...

    Julien Delrieu, Thierry Voisin, ... Sandrine Andrieu in Alzheimer's Research & Therapy
    Article Open access 19 October 2020
  18. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

    Most Alzheimer disease (AD) patients present as sporadic late onset AD, with metabolic factors playing an important role in the occurrence and...

    Jing Xiong, Isaac Deng, ... Xin-Fu Zhou in Metabolic Brain Disease
    Article 15 June 2022
  19. The Role of Tau Proteoforms in Health and Disease

    Tau is a microtubule-associated binding protein in the nervous system that is known for its role in stabilizing microtubules throughout the nerve...

    Zuha Waheed, Jawaria Choudhary, ... Saima Zafar in Molecular Neurobiology
    Article 02 June 2023
Did you find what you were looking for? Share feedback.